首页> 外文期刊>Circulation research: a journal of the American Heart Association >Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction: A Multicenter Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
【24h】

Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction: A Multicenter Randomized, Double-Blind, and Placebo-Controlled Clinical Trial

机译:同种异体人体心脏干细胞患者在ST段抬高心肌梗死和左心室功能障碍患者中输注同种异体人心脏干细胞的安全性和有效性:多中心随机,双盲和安慰剂对照临床试验

获取原文
获取原文并翻译 | 示例
       

摘要

Rationale: Allogeneic cardiac stem cells (AlloCSC-01) have shown protective, immunoregulatory, and regenerative properties with a robust safety profile in large animal models of heart disease.
机译:基本原理:同种异体心脏干细胞(AlloCSC-01)显示了在心脏病大型动物模型中具有稳健的安全性的保护性,免疫调节和再生性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号